A few months ago, you wrote about the benefits of the shingles vaccine. At 63, I’m one of the 1% who has never had, nor been exposed to, ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Newport Police reported the arrest of a Charleston man wanted for the theft of a vehicle in Newport City. Harold Nadeau Jr., ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

If you double up on your dose, it is possible to overdose on Ozempic. Here's what to know—including side effects and what to ...